These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35606187)

  • 21. Inositol 1,4,5-trisphosphate receptor type 1 autoantibody (ITPR1-IgG/anti-Sj)-associated autoimmune cerebellar ataxia, encephalitis and peripheral neuropathy: review of the literature.
    Jarius S; Bräuninger S; Chung HY; Geis C; Haas J; Komorowski L; Wildemann B; Roth C
    J Neuroinflammation; 2022 Jul; 19(1):196. PubMed ID: 35907972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneously occurring neutralizing antibodies against granulocyte-macrophage colony-stimulating factor in patients with autoimmune disease.
    Meager A; Wadhwa M; Bird C; Dilger P; Thorpe R; Newsom-Davis J; Willcox N
    Immunology; 1999 Jul; 97(3):526-32. PubMed ID: 10447777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Presence of cerebrospinal fluid antibodies associated with autoimmune encephalitis of humans in dogs with neurologic disease.
    Stafford EG; Kortum A; Castel A; Green L; Lau J; Early PJ; Muñana KR; Mariani CL; Yoder JA; Olby NJ
    J Vet Intern Med; 2019 Sep; 33(5):2175-2182. PubMed ID: 31495976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations.
    Endres D; Leypoldt F; Bechter K; Hasan A; Steiner J; Domschke K; Wandinger KP; Falkai P; Arolt V; Stich O; Rauer S; Prüss H; van Elst LT
    Eur Arch Psychiatry Clin Neurosci; 2020 Oct; 270(7):803-818. PubMed ID: 32166503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis: Serum anti-CNS autoantibodies.
    Prineas JW; Parratt JDE
    Mult Scler; 2018 Apr; 24(5):610-622. PubMed ID: 28548612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum and cerebrospinal fluid autoantibodies in patients with neuropsychiatric lupus erythematosus. Implications for diagnosis and pathogenesis.
    Fragoso-Loyo H; Cabiedes J; Orozco-Narváez A; Dávila-Maldonado L; Atisha-Fregoso Y; Diamond B; Llorente L; Sánchez-Guerrero J
    PLoS One; 2008 Oct; 3(10):e3347. PubMed ID: 18836530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients.
    Flanagan EP; Hinson SR; Lennon VA; Fang B; Aksamit AJ; Morris PP; Basal E; Honorat JA; Alfugham NB; Linnoila JJ; Weinshenker BG; Pittock SJ; McKeon A
    Ann Neurol; 2017 Feb; 81(2):298-309. PubMed ID: 28120349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus.
    Golombek SJ; Graus F; Elkon KB
    Arthritis Rheum; 1986 Sep; 29(9):1090-7. PubMed ID: 3753538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.
    Hellmich B; Ciaglo A; Schatz H; Coakley G
    Ann Rheum Dis; 2004 Jul; 63(7):862-6. PubMed ID: 15194585
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Screening for autoantibodies in inflammatory neurological syndrome using fluorescence pattern in a tissue-based assay: Cerebrospinal fluid findings from 793 patients.
    Liu T; Chen B; Yang H; Huang J; Liu S; Yang X; Huang L; Yao H; Qiu W; Zhuang H; Long Y; Gao C
    Mult Scler Relat Disord; 2019 Feb; 28():177-183. PubMed ID: 30611927
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: Results from 108 lumbar punctures in 80 pediatric patients.
    Jarius S; Lechner C; Wendel EM; Baumann M; Breu M; Schimmel M; Karenfort M; Marina AD; Merkenschlager A; Thiels C; Blaschek A; Salandin M; Leiz S; Leypoldt F; Pschibul A; Hackenberg A; Hahn A; Syrbe S; Strautmanis J; Häusler M; Krieg P; Eisenkölbl A; Stoffels J; Eckenweiler M; Ayzenberg I; Haas J; Höftberger R; Kleiter I; Korporal-Kuhnke M; Ringelstein M; Ruprecht K; Siebert N; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B; Rostásy K;
    J Neuroinflammation; 2020 Sep; 17(1):262. PubMed ID: 32883358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus.
    Hirohata S; Arinuma Y; Yanagida T; Yoshio T
    Arthritis Res Ther; 2014 Mar; 16(2):R77. PubMed ID: 24655341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-MOG autoantibody-associated schizophreniform psychosis.
    von Zedtwitz K; Matteit I; Michel M; Feige B; Runge K; Denzel D; Schlump A; Nickel K; Schiele MA; Berger B; Prüss H; Urbach H; Domschke K; Tebartz van Elst L; Endres D
    Acta Neuropsychiatr; 2022 Feb; 34(1):47-54. PubMed ID: 34493350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoantibody-associated psychiatric symptoms and syndromes in adults: A narrative review and proposed diagnostic approach.
    Hansen N; Lipp M; Vogelgsang J; Vukovich R; Zindler T; Luedecke D; Gingele S; Malchow B; Frieling H; Kühn S; Denk J; Gallinat J; Skripuletz T; Moschny N; Fiehler J; Riedel C; Wiedemann K; Wattjes MP; Zerr I; Esselmann H; Bleich S; Wiltfang J; Neyazi A;
    Brain Behav Immun Health; 2020 Dec; 9():100154. PubMed ID: 34589896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment].
    Tebartz van Elst L; Bechter K; Prüss H; Hasan A; Steiner JH; Leypoldt F; Endres D
    Nervenarzt; 2019 Jul; 90(7):745-761. PubMed ID: 31197396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Signs of impaired blood-brain barrier function and lower IgG synthesis within the central nervous system in patients with schizophrenia or related psychosis, compared to that in controls.
    Melkersson K; Bensing S
    Neuro Endocrinol Lett; 2018 Mar; 39(1):33-42. PubMed ID: 29803205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Granulocyte/macrophage-colony-stimulating factor autoantibodies and myeloid cell immune functions in healthy subjects.
    Uchida K; Nakata K; Suzuki T; Luisetti M; Watanabe M; Koch DE; Stevens CA; Beck DC; Denson LA; Carey BC; Keicho N; Krischer JP; Yamada Y; Trapnell BC
    Blood; 2009 Mar; 113(11):2547-56. PubMed ID: 19282464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-GM-CSF autoantibodies in patients with cryptococcal meningitis.
    Rosen LB; Freeman AF; Yang LM; Jutivorakool K; Olivier KN; Angkasekwinai N; Suputtamongkol Y; Bennett JE; Pyrgos V; Williamson PR; Ding L; Holland SM; Browne SK
    J Immunol; 2013 Apr; 190(8):3959-66. PubMed ID: 23509356
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual-Targeted Autoimmune Sword in Fatal Epilepsy: Patient's glutamate receptor AMPA GluR3B peptide autoimmune antibodies bind, induce Reactive Oxygen Species (ROS) in, and kill both human neural cells and T cells.
    Levite M; Zelig D; Friedman A; Ilouz N; Eilam R; Bromberg Z; Ramadhan Lasu AA; Arbel-Alon S; Edvardson S; Tarshish M; Riek LP; Lako RL; Reubinoff B; Lebendiker M; Yaish D; Stavsky A; Galun E
    J Autoimmun; 2020 Aug; 112():102462. PubMed ID: 32561150
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.